Release Date: 10/02/20 09:03 Summary: Matallurgical Testwork Report Received Price Sensitive: Yes Download Document 173.25KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%